Gevork I. Minaskanian
Gründer bei ADERIS Pharmaceuticals, Inc.
Profil
Gevork I.
Minaskanian is a Co-Founder and Vice President of Chemistry for ADERIS Pharmaceuticals, Inc. He is an Adjunct Professor of Chemistry at Virginia Commonwealth University.
Prior to joining Aderis, Dr. Minaskanian was Principal Research Scientist of Whitby Research, Inc. (previously Nelson Research and Development).
He received a PhD from Texas Tech University.
Aktive Positionen von Gevork I. Minaskanian
| Unternehmen | Position | Beginn |
|---|---|---|
ADERIS Pharmaceuticals, Inc.
 ADERIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ADERIS Pharmaceuticals, Inc. develops and commercializes drugs and pharmaceuticals. It engages in small molecule drug development to treat central nervous system, cardiovascular, and inflammatory disorders. The company was founded by Donald McAfee, Noel Cusack, Gevork I. Minaskanian, and Peter Savasand in 1994 and is headquartered in Hopkinton, MA. | Gründer | 01.01.1994 |
| Virginia Commonwealth University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Gevork I. Minaskanian
| Unternehmen | Position | Ende |
|---|---|---|
| Whitby Research, Inc. | Corporate Officer/Principal | - |
Ausbildung von Gevork I. Minaskanian
| Texas Tech University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
ADERIS Pharmaceuticals, Inc.
ADERIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ADERIS Pharmaceuticals, Inc. develops and commercializes drugs and pharmaceuticals. It engages in small molecule drug development to treat central nervous system, cardiovascular, and inflammatory disorders. The company was founded by Donald McAfee, Noel Cusack, Gevork I. Minaskanian, and Peter Savasand in 1994 and is headquartered in Hopkinton, MA. | Health Technology |
| Whitby Research, Inc. |
